BioCentury
ARTICLE | Company News

Elan, Schein Pharmaceutical Inc. sales and marketing update

May 24, 1999 7:00 AM UTC

Schein will exclusively market in the U.S. ELN's Verapamil sustained-release capsules to treat hypertension. ...